B. Metzler seel. Sohn & Co. AG Makes New $17.61 Million Investment in Danaher Corporation $DHR

Key Points

• B. Metzler seel. Sohn & Co. AG initiated a $17.61 million position in Danaher during the second quarter by purchasing 92,424 shares. Institutional investors collectively own 79.05% of the company.
• Danaher exceeded quarterly expectations, reporting adjusted earnings of $1.94 per share versus the $1.85 consensus and revenue of $6.26 billion. Revenue increased 5.5% year over year.
• Analysts maintain a generally positive view, with Danaher holding a “Moderate Buy” consensus rating and an average price target of $228.91, compared with a reported share price of $219.42.

B. Metzler seel. Sohn & Co. AG bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 92,424 shares of the conglomerate's stock, valued at approximately $17,605,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. BlackRock Inc. bought a new position in shares of Danaher in the 2nd quarter worth $10,492,520,000. State Street Corp increased its stake in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate's stock valued at $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Capital International Investors lifted its position in shares of Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate's stock worth $4,177,386,000 after buying an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate's stock worth $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate's stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 1.6%

NYSE:DHR opened at $219.42 on Friday. The stock has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a 50-day moving average price of $195.80 and a 200-day moving average price of $192.61. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 earnings per share. Equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Evercore restated an "outperform" rating and set a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Wolfe Research cut Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. Argus lowered their price target on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Friday, April 24th. Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They set a "buy" rating and a $230.00 price target for the company. Finally, Guggenheim reduced their price objective on Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and an average target price of $228.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source